Following the publication of this article [1], similarities were noted between this article and articles submitted by other research groups, including [2-10], of which one article [10] was previously retracted [11].Similarities included the following figures, which appear to fully or partially overlap, despite being published in different articles and representing different conditions:miR-33b inhibitor panels in Fig 2C and 2D of [1], and inhibitors panel in Fig 3D of [3].control panel in Fig 4C of [1], and untreated panel in Fig 2D of [2].pCDNA-c-Myc + scramble panel in Fig 4C of [1] and inhibitor panel in Fig 2C of [2].Although the corresponding author initially replied to acknowledge receipt of our message, PLOS ONE did not receive responses to the queries regarding these concerns by the end of the original deadline and extension.The unresolved concerns call into question the validity and provenance of the reported results and the adherence of this article to the PLOS Authorship policy. Therefore, the PLOS ONE Editors retract this article [1].All authors did not comment on the retraction decision, did not respond directly or could not be reached.